Sensory neuromuscular electrical stimulation for dysphagia rehabilitation: A literature review.

deglutition dysphagia dysphagia rehabilitation sensory neuromuscular electrical stimulation suprahyoid muscle swallowing

Journal

Journal of oral rehabilitation
ISSN: 1365-2842
Titre abrégé: J Oral Rehabil
Pays: England
ID NLM: 0433604

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 23 08 2022
received: 21 04 2022
accepted: 02 11 2022
pubmed: 11 11 2022
medline: 12 1 2023
entrez: 10 11 2022
Statut: ppublish

Résumé

Dysphagia is a common disorder following a cerebrovascular accident. It can cause detrimental effects on patient's quality of life and nutrition intake, especially in older adults. Neuromuscular electrical stimulation has been one of the management strategies for acceleration of the recovery. This review summarises the current evidence on sensory threshold stimulation of the procedure. This review compiled data from the Internet database PubMed, Cochrane Library and Scopus using combination of MeSH thesaurus: 'Sensory threshold', 'electrical stimulation', 'neuromuscular stimulation', 'Deglutition', 'Dysphagia'. Eleven studies were intergraded into the review. Most of the studies show significant improvement to the outcomes of sensory neuromuscular electrical stimulation treatment. In many cases, the results of the treatment are comparable or superior to motor threshold stimulation and conventional therapy. However, the study design and parameters of the procedure varied greatly without conclusive standardised guidelines. The sensory neuromuscular electrical stimulation (SNMES) is a viable treatment option for treating oropharyngeal dysphagia. The most suggested application parameters are an intensity at sensory threshold, a frequency of 80 Hz, an impulse time of 700 μs, a combined total duration of 20 h of stimulation in a 2-week period, and placing the electrodes in the submental area of the neck. However, further research is necessary to construct a definitive guideline for clinicians.

Sections du résumé

BACKGROUND BACKGROUND
Dysphagia is a common disorder following a cerebrovascular accident. It can cause detrimental effects on patient's quality of life and nutrition intake, especially in older adults. Neuromuscular electrical stimulation has been one of the management strategies for acceleration of the recovery. This review summarises the current evidence on sensory threshold stimulation of the procedure.
METHOD METHODS
This review compiled data from the Internet database PubMed, Cochrane Library and Scopus using combination of MeSH thesaurus: 'Sensory threshold', 'electrical stimulation', 'neuromuscular stimulation', 'Deglutition', 'Dysphagia'. Eleven studies were intergraded into the review.
RESULTS RESULTS
Most of the studies show significant improvement to the outcomes of sensory neuromuscular electrical stimulation treatment. In many cases, the results of the treatment are comparable or superior to motor threshold stimulation and conventional therapy. However, the study design and parameters of the procedure varied greatly without conclusive standardised guidelines.
CONCLUSION CONCLUSIONS
The sensory neuromuscular electrical stimulation (SNMES) is a viable treatment option for treating oropharyngeal dysphagia. The most suggested application parameters are an intensity at sensory threshold, a frequency of 80 Hz, an impulse time of 700 μs, a combined total duration of 20 h of stimulation in a 2-week period, and placing the electrodes in the submental area of the neck. However, further research is necessary to construct a definitive guideline for clinicians.

Identifiants

pubmed: 36357332
doi: 10.1111/joor.13391
pmc: PMC10286766
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-164

Subventions

Organisme : Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan
ID : K22K100920

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

J Oral Rehabil. 2016 Jun;43(6):426-34
pubmed: 26969528
J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):73-76
pubmed: 21336727
Acta Neurol Belg. 2020 Oct;120(5):1097-1105
pubmed: 30604337
SAGE Open Med. 2020 Dec 14;8:2050312120974152
pubmed: 33403111
Arch Phys Med Rehabil. 2016 Mar;97(3):355-62
pubmed: 26606872
Stroke. 2005 Dec;36(12):2756-63
pubmed: 16269630
Ann Otol Rhinol Laryngol. 2002 Apr;111(4):291-4
pubmed: 11991578
Neuron. 2002 May 30;34(5):831-40
pubmed: 12062028
Neurogastroenterol Motil. 2013 Nov;25(11):888-e701
pubmed: 23937476
Nat Neurosci. 1998 May;1(1):64-8
pubmed: 10195111
Stroke. 1999 Apr;30(4):744-8
pubmed: 10187872
Brain Struct Funct. 2014 Jul;219(4):1493-507
pubmed: 23700106
J Comp Neurol. 1999 Sep 27;412(3):410-28
pubmed: 10441230
Dysphagia. 2010 Dec;25(4):323-33
pubmed: 20814803
Dysphagia. 2012 Mar;27(1):94-100
pubmed: 21607745
Folia Phoniatr Logop. 2013;65(3):154-68
pubmed: 24356211
Cereb Cortex. 2006 Aug;16(8):1106-15
pubmed: 16221926
Neurorehabil Neural Repair. 2010 Mar-Apr;24(3):263-72
pubmed: 19884642
Neurorehabil Neural Repair. 2009 May;23(4):351-6
pubmed: 18981187
PLoS One. 2017 Mar 29;12(3):e0174522
pubmed: 28355265
Stroke. 2003 Apr;34(4):975-81
pubmed: 12637700
J Rehabil Med. 2009 Feb;41(3):174-8
pubmed: 19229451
Neurorehabil Neural Repair. 2011 Feb;25(2):188-93
pubmed: 20947491
Ann N Y Acad Sci. 2016 Sep;1380(1):121-138
pubmed: 27398981
Neuroimage. 2009 Feb 1;44(3):982-91
pubmed: 19010424
Neurogastroenterol Motil. 2021 Jan;33(1):e13938
pubmed: 32656920
Ann Rehabil Med. 2014 Oct;38(5):592-602
pubmed: 25379488
Brain Res. 2006 Nov 13;1119(1):124-32
pubmed: 16962076
BMC Neurosci. 2009 Jun 30;10:71
pubmed: 19566955
Science. 1998 Mar 13;279(5357):1714-8
pubmed: 9497289
Stroke Res Treat. 2014;2014:918057
pubmed: 24804147
Arch Phys Med Rehabil. 2019 Apr;100(4):739-750.e4
pubmed: 30352222
Dysphagia. 2015 Aug;30(4):423-9
pubmed: 25917017
Stroke Res Treat. 2015;2015:429053
pubmed: 26689491
Laryngoscope. 1999 Dec;109(12):1974-7
pubmed: 10591357
Physiol Rev. 2001 Apr;81(2):929-69
pubmed: 11274347
J Oral Rehabil. 2023 Feb;50(2):157-164
pubmed: 36357332
Stroke. 2003 Jun;34(6):1553-66
pubmed: 12738893
J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106554
pubmed: 35691184
Curr Opin Neurol. 2005 Dec;18(6):667-74
pubmed: 16280678
Dysphagia. 2010 Dec;25(4):291-7
pubmed: 19856025
Neurorehabil Neural Repair. 2018 Oct;32(10):863-871
pubmed: 30198383
Gastroenterol Hepatol (N Y). 2011 May;7(5):308-32
pubmed: 21857832
Dysphagia. 2016 Oct;31(5):706-16
pubmed: 27503566
J Physiol. 1998 Feb 1;506 ( Pt 3):857-66
pubmed: 9503343
Neurorehabil Neural Repair. 2011 Nov-Dec;25(9):799-809
pubmed: 21746874
Clin Interv Aging. 2017 Nov 07;12:1879-1886
pubmed: 29158670

Auteurs

Itt Assoratgoon (I)

Division of Advanced Prosthetic Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.
Chulalongkorn University, Bangkok, Thailand.

Naru Shiraishi (N)

Division of Advanced Prosthetic Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.
Center for Dysphagia of Tohoku University Hospital, Sendai, Japan.

Ryo Tagaino (R)

Center for Dysphagia of Tohoku University Hospital, Sendai, Japan.
Maxillofacial Prosthetics Clinic, Tohoku University Hospital, Sendai, Japan.

Toru Ogawa (T)

Division of Advanced Prosthetic Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.

Keiichi Sasaki (K)

Division of Advanced Prosthetic Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH